Dexmedetomidine for Continuous Sedation

Clinical trial NCT00226785 · TERMINATED

Trial details

NCT number: NCT00226785
Sponsor: Orion Corporation, Orion Pharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Conscious Sedation

Start date: 2005-10-01
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.